{"product_id":"retratutide-injection","title":"RETRATUTIDE INJECTION 40mg","description":"\u003cp\u003eRetatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-1\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e, studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-2\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-3\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e. With an extended half-life of approximately 6 days, this peptide enables convenient\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eonce-weekly subcutaneous\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003edosing with a gradual titration protocol to optimize tolerability\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-1\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-4\"\u003e[4]\u003c\/a\u003e\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eReconstitute:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAdd\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2.0 mL\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ebacteriostatic water →\u003cspan\u003e \u003cstrong\u003e2\u003c\/strong\u003e\u003c\/span\u003e\u003cstrong\u003e0.0 mg\/mL\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003econcentration for optimal weekly doses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTypical weekly range:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2–12 mg\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eonce weekly (gradual escalation over 12+ weeks).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy measuring:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAt 10.0 mg\/mL,\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e1 unit = 0.01 mL ≈ 200 mcg\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eon a U-100 insulin syringe.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eLyophilized: freeze at\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e−20 °C (−4 °F)\u003c\/strong\u003e; after reconstitution, refrigerate at\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2–8 °C (35.6–46.4 °F)\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand use within 2–4 weeks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2 id=\"standard-gradual-titration-approach-2-ml-100-mgml-2\"\u003eStandard \/ Gradual Titration Approach (2 mL = 10.0 mg\/mL)\u003c\/h2\u003e\n\u003cdiv class=\"table-responsive\"\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eWeek(s)\u003c\/th\u003e\n\u003cth\u003eWeekly Dose (mcg) (mg)\u003c\/th\u003e\n\u003cth\u003eUnits (per injection) (mL)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 1–4\u003c\/td\u003e\n\u003ctd\u003e2,000 mcg (2 mg)\u003c\/td\u003e\n\u003ctd\u003e10 units (0.20 mL)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 5–8\u003c\/td\u003e\n\u003ctd\u003e4,000 mcg (4 mg)\u003c\/td\u003e\n\u003ctd\u003e20 units (0.40 mL)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 9–12\u003c\/td\u003e\n\u003ctd\u003e8,000 mcg (8 mg)\u003c\/td\u003e\n\u003ctd\u003e40 units (0.80 mL)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeeks 13+\u003c\/td\u003e\n\u003ctd\u003e12,000 mcg (12 mg)\u003c\/td\u003e\n\u003ctd\u003e60 units (1.20 mL) —\u003cspan\u003e \u003c\/span\u003e\u003cem\u003esplit into 2 injections or use 2 vials\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eFrequency:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eInject\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eonce weekly\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003esubcutaneously. This schedule follows clinical trial protocols that demonstrated significant weight loss (up to 24% at 48 weeks with 12 mg weekly)\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-2\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e\u003cspan\u003e \u003c\/span\u003ewhile minimizing gastrointestinal adverse events through gradual escalation\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-1\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e\u003csup\u003e\u003ca href=\"https:\/\/peptidedosages.com\/single-peptide-dosages\/retatrutide-20-mg-vial-dosage-protocol\/#ref-4\"\u003e[4]\u003c\/a\u003e\u003c\/sup\u003e. Starting at 2 mg weekly (versus 4 mg) significantly reduces initial GI side effects. The 20 mg vial size with 2.0 mL reconstitution provides excellent concentration (10.0 mg\/mL) for convenient measuring. For the maintenance dose (12 mg = 1.20 mL), either split into two 0.60 mL injections at different sites or reconstitute an additional vial.\u003c\/p\u003e\n\u003ch3 id=\"reconstitution-steps-3\"\u003eReconstitution Steps\u003c\/h3\u003e\n\u003col\u003e\n\u003cli\u003eDraw\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2.0 mL\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ebacteriostatic water with a sterile syringe.\u003c\/li\u003e\n\u003cli\u003eInject slowly down the vial wall; avoid foaming.\u003c\/li\u003e\n\u003cli\u003eGently swirl\/roll until dissolved (do not shake vigorously).\u003c\/li\u003e\n\u003cli\u003eLabel with reconstitution date and refrigerate at\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2–8 °C (35.6–46.4 °F)\u003c\/strong\u003e, protected from light.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eThe 20 mg vial size is highly efficient for weekly protocols. Lower doses (2–8 mg) fit comfortably in a single syringe, while the maintenance dose (12 mg) requires either splitting across two injection sites or using a second vial for the remaining 0.20 mL (2 mg).\u003c\/em\u003e\u003c\/p\u003e","brand":"USA Peptides","offers":[{"title":"Default Title","offer_id":47177205088505,"sku":null,"price":0.0,"currency_code":"PYG","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0790\/5394\/7129\/files\/Retratutidefrente.png?v=1767699387","url":"https:\/\/zenithlabsusa.com\/products\/retratutide-injection","provider":"USA Peptides","version":"1.0","type":"link"}